ArticleBiomedicines2021

Novel Pharmaceutical Strategy for Selective Abrogation of TSP1-Induced Vascular Dysfunction by Decoy Recombinant CD47 Soluble Receptor in Prophylaxis and Treatment Models.

Molly Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.